Introduction
An important goal in the field of human genetics is to understand the relationship between gene function and disease pathophysiology. Cystic fibrosis (CF) is the most common lethal genetic disorder in the Caucasian population, and is caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR). We, and others, have produced mouse models for CF in which mutations have been introduced into the murine CFTR gene (Cftr) by homologous recombination in embryonal stem (ES) cells (reviewed in Dorin et al., 1994a ). These animals demonstrate both the characteristic CF chloride defect and intestinal pathology typical of this disease. They have also proved useful in pre-clinical studies of CFTR gene transfer using correction of the chloride transport deficit as the primary measure of efficacy (Alton et al., 1993; Hyde et al., 1993; Grubb et al., 1994) . However, the available models carry grossly disrupted Oxford University Press alleles, resulting either in no CFTR protein, exemplified by the 'null' cftr-In'UNCgene replacement event (Snouwaert et al., 1992) , or very low levels of normal protein, as in the case of the Cftr-nlHGU gene insertion event (Dorin et al., 1994b) . In contrast, the majority of CF patients carry subtle mutations which result in the production of a dysfunctional mutant protein (Tsui, 1992) . The effect of ectopic expression of normal CFTR on a mutant CFTR background is unknown and it may, therefore, be important and instructive to carry out such gene transfer studies in a mouse engineered to carry a mutant form of CFTR equivalent to that which occurs in CF subjects.
G551D is one of the most ancient and common CF mutations, with a world-wide frequency averaging 3% but found at higher frequencies in populations of Celtic descent (Hamosh et al., 1992) . In humans, G55 lD CFTR protein is processed normally but produces cAMP-regulated chloride channels showing markedly reduced function (Class III mutation) (Welsh and Smith, 1993) . A key aspect of this mutation is the 3-fold reduction in the incidence of meconium ileus (neonatal intestinal blockage) in CF patients carrying the G55 1 D mutation compared with patients homozygous for the most common CFTR mutation, AF508 (Hamosh et al., 1992) . We have used a singlestep targeting strategy to introduce the human missense mutation G551D into mice, allowing us to determine whether this protective effect is substantiated across species and allowing for the first time the examination of CF genotype-phenotype correlations in the laboratory.
We have examined the histological features and determined the electrophysiological responses of the G55iD mutant mice, and show that the phenotype is intermediate between that of existing cfti-'/IUNc replacement ('null') and cft,,IHGU insertional (residual activity) mutant mice.
Importantly, intestinal blockage is reduced and survival increased in comparison with the 'null' cftenlUNC mutant mouse, mimicking the mild intestinal phenotype of G55 ID patients. In man, only a small number of CF phenotypegenotype correlations have been established (Hamosh and Cutting, 1993 (Delaney et al., 1993) . Targeting of the Cftr locus in ES cells by homologous recombination was identified by Southern blot analysis (Figure I B) . This occurred in 37 of 96 ES colonies obtained under positive/ negative selection. Fifteen of 18 targeted colonies tested by allele-specific PCR retained the G551D allele. Five of these lines were used to generate chimaeric animals, and two males from independent cell lines showed germ-line transmission. Approximately half of the progeny of the two transmitting males were heterozygous for the G55 1D allele, as determined by allele-specific PCR (data not shown). We have designated this allele cftrTgHmIG55sD but will refer to it in this manuscript as cftrGS5ID. These heterozygous animals were inter-crossed to produce wildtype (+/+), heterozygous (+/cftrG551D) and homozygous mutant (cftrGS/DIcftrGSSID) offspring. In agreement with the expected ratio of 1:2:1, in 123 animals genotyped from these crosses, 23% were +/+, 48% were +/cftrG55ID and 29% were cftrG55D/cftrG55ID. RT-PCR carried out on RNA prepared from a variety of tissues from heterozygous and homozygous animals indicated that selectable marker sequences retained in the targeted allele were not being incorporated as novel additional exons into CFTR transcripts ( Figure IC) . Semi-quantitative RT-PCR indicated that the level of transcription of the G551D allele in a variety of tissues was~53% of that of the wild-type allele ( Figure ID ).
Intestinal obstruction is responsible for perinatal lethality and is reduced in G551D mutant mice compared with cftrJnlUNC ('null') mice In crosses between heterozygous animals, cftrG55DI cftrG55D offspring were runted and between 50 and 70% of the weight of normal siblings. In matings maintained in specific pathogen-free conditions,~33% of homozygous animals (46/141) died from intestinal obstruction before 35 days after birth (Figure 2 ). The site of intestinal obstruction in most animals, regardless of age, was just (Dorin reason for the reduction in survival of common facility is uncertain, but mos transfer from a specific pathogen-free ti facility and a concomitant change of foc of the lung, crenation of the airway epithelia and epithelial hyperplasia. Using these criteria, no difference could be detected between homozygous animals and control siblings. No abnormalities were detected in the epithelia of the trachea or pharynx of nine cftrG55 !)cftrG55ID
animals, but three showed inspissated eosinophilic material W ,M.M.M.-Onru.'" in the lumen of the pharyngeal submucosal glands ( Figure  4A and B). In three of seven mutant animals suffering from intestinal obstruction, the gallbladder appeared black and enlarged. Abnormalities were also evident in a number of ID * healthy mutant animals, and included gallbladders which were black, enlarged or reduced in size. Five of nine gallbladders from cftrGSSlD/cftr G55D animals showed the presence of large numbers of polymorphonuclear cells, particularly eosinophils, in the gallbladder wall. In two of these animals, the gallbladder wall had an extremely vacuolated appearance in addition to the presence of inflammatory cells ( Figure 4C and D). Abnormalities were 40 50 60 also evident in the biliary tree of the liver. In three of 15
animals there was hyperplasia of the bile duct epithelia
The survival of and in one of these animals there were bile pigments in ons is shown. the hepatocytes. Another of these three apparently healthy 51D n = 67. mutant animals showed focal biliary cirrhosis. In the area of focal cirrhosis, the biliary ducts were completely absent and were replaced by a fibrotic stroma and an inflammatory the cause of death infiltrate characterized by large numbers of eosinophils tinal perforation.
( Figure 4E and F). Elsewhere in the liver, other than vival of mice carrysome bile ducts showing hyperplasia, the tissue was ails were reared and unremarkable. ival at 35 days was Salivary gland defects have been reported in CF indind 27% (12/44) for viduals and other CF mouse models (Ratcliff et al., 1993) .
nlIHGU mutants was
In two out of 10 GS51D animals examined, the gland Figure 3B ). The most characteristic abnormality found in all of the apparently healthy mutant mice examined was the presence of eosinophilic concretions in the crypts of Lieberkuhn. This results in the dilation of some crypts, particularly in the jejunum ( Figure  3C and D). The colon of some animals also showed dilated mucus glands (data not shown).
In keeping with previous studies of the cftr*llnUNC (Snouwaert et al., 1992) and CftrPnIHGU mutant mice (Dorin et al., 1992) Figure SA and B) . The baseline PD profile closely resembles that seen in man, with a gradual increase in PD within the nasal cavity. Furthermore, the maximal value was reached at a greater distance from the external nares in the mutant mice, similar to the case in CF subjects. Subsequent perfusion with the cAMP-related agonist forskolin produced no response in the mutant mice; typically a depolarization was seen ( Figure 5C ). Finally, perfusion with ATP produced no significant difference between the calcium-related chloride secretion of the two genotypes ( Figure 5D ). In the trachea, in vitro measurements of baseline short circuit current (ISC) Throughout the intestinal tract, whether studied in vitro (jejunum and caecum) or in vivo (rectum), both baseline values and the response to forskolin were significantly (P<0.001) reduced (Figure 6 ). We, and others, have demonstrated previously that the response of wild-type mice to forskolin principally relates to chloride secretion (Alton et al., 1993) . This was confirmed in the present study by the subsequent addition of bumetanide ( Figure  6 ). We also attempted to assess the effect of ionomycin (5 ,uM) added at the peak of the forskolin response. In both genotypes, this addition produced variable small changes, in keeping with CFTR acting as the principal chloride channel in the intestinal tract. Thus, in all tissues studied, the animals are characterized by a marked reduction in CFTR-related bioelectric responses.
The 
Discussion
We have used a single-step gene targeting procedure to produce mice carrying the equivalent of the common human mutation G55 1D by placing the marker sequences necessary to select for homologous recombination events adjacent to an exon which is skipped in somatic cells. In common with existing CFTR 'null' mouse mutants, G55 1 D mutant mice display runting, intestinal obstruction, gallbladder abnormalities and alterations in serous and mucous glands, and show an absence of frank pathology in the lungs, pancreas and reproductive tract. The pathological changes seen in the liver and biliary tract are similar to the focal biliary cirrhosis seen in 5% of CF patients (Park and Grand, 1991) the increased longevity of these mice compared with cftrlIUNC 'null' mutants and reduced residual CFTRrelated chloride transport function compared with cftenIHGU mutants which have -10% wild-type CFTR mRNA (Dorin et al., 1994b (Logan et al., 1994 the mutant protein (Drumm et al., 1991 systems studied and the inclusion of 3-isobutyl-l-methylxanthine (IBMX) in the stimulant cocktail. Phosphodiesterase inhibitors such as IBMX have been shown recently to activate G551D channels (Becq et al., 1994) , and suggest a therapeutic approach which may be tested in the cftrGSSID mice.
Reduced cAMP, but not calcium-mediated chloride transport, was observed in the airways of the G55iD mutants, as predicted from previous studies of CFTR
function. We also demonstrate in the mouse that the G55 ID mutation increases sodium transport in the airways.
To our knowledge, this has only been reported previously for CF subjects with either Class I 'null' mutations (and a complete absence of cellular CFTR) or Class II mutants, such as AF508 (in which the mutant protein is localized to the cytoplasm). Our results suggest that fully functional CFTR localized to the apical membrane appears to be necessary to prevent an increase in sodium absorption in the airways. We measured a small, but significantly elevated response to forskolin in the caecum of G55 1D mice compared with 'null' mutants which had a marked effect on survival. As many as 67% of G55 lD mutant mice survived to 35 days when housed under specific pathogen-free conditions. Under conventional animal housing, survival was reduced to 27%, but this was still significantly higher than for complete 'null' mutants (8% survival; P<0.05). The improved survival of cftrGSSD/cftr G55D animals versus cfteInlUNC/cftemlUNC mice is in accord with the clinical picture where CF patients bearing the G551D allele are indistinguishable in all respects from AF508 homozygotes except for a 3-fold decrease in risk of meconium ileus (Hamosh et al., 1992) . This genotype-phenotype correlation is therefore substantiated across species, and the residual bioelectric responses in G551D animals probably explain these findings. The production of these G55iD mice illustrates how mouse models carrying clinically relevant mutations may be of use in establishing mechanisms which underlie genotype-phenotype correlations.
The survival of the cftrGSSD homozygous mice is clearly improved over that for the cfteIUNC homozygotes, despite only a very low level of residual cAMP-mediated chloride conductance. This provides evidence for a phenotypic effect accruing from only a modest level of normal CFTR chloride channel function (in the caecum equivalent to -5% of wild-type function). This is encouraging with respect to both gene therapy and pharmacological-based strategies for the treatment of CF. Our results also complement those of Zhou et al. (1994) who recently reported that transgenic expression of the human CFTR transgene driven by the FABP promoter, active in intestinal villus cells, restored~30% of the cAMP-mediated chloride conductance, sufficient to substantially rescue the cft)n IUNC mutant strain from fatal intestinal disease.
The resulting good survival of the G55 1D mice means they provide an excellent model with which to study other aspects of CF pathogenesis, for example involving the lung and liver. We have recently shown that cft,nIHGU mice develop lung disease on exposure to CF-related pathogens (Davidson et al., 1995) . It will be of interest to establish whether the G551D mice, which have less residual CFTR function than the CfteJ)HGU mice, develop more severe lung disease that might recapitulate the chronic infection found in patients. These animals are the first CF mice to be produced to carry a Class III mutation, which occur in a significant number of CF patients. In contrast to the most common CFTR mutation (AF508), Class III mutations result in CFTR which is able to reach the apical membrane. These mice will therefore also be of value in testing treatment strategies that may only be applicable to this type of mutation, for example activation by pharmacological agents which alter CFTR regulation.
Materials and methods

Construction of the G551D targeting vector
A phage clone was isolated from an 129-Sv genomic library using a primer homologous to exon 11 sequences (nt 1721-1742) and contained exons 11, lb, 12 and 13. The G55lD mutation was introduced into exon 11 by PCR with Vent polymerase (New England Biolabs) using the primer (5'-CACTG AGTGG AGACC AGCGT GC-3'). Mutagenized clones were checked for PCR errors in coding regions, and a fragment containing exon 11 and 12 was used to replace the equivalent wild-type sequences in a subclone containing 6.3 kb of Cftr genomic DNA. A HSV-TK cassette was inserted at the 3' end of the insert (Mansour et al., 1988) . Two pgk-neo cassettes (Tybulewicz et al., 1991) , as used in other Cftr replacement constructs (Koller et al., 1991) , were inserted 8 bp downstream of exon II b.
Production of targeted lines and mutant mice RI ES cells were maintained and selected on primary embryonic fibroblasts (Wurst and Joyner, 1993) with leukaemia inhibitory factor (LIF) added to the media at 1000 U/ml. Chimaeric animals were produced by the aggregation method essentially as described for tetraploid aggregation by Nagy and Rossant (1993) , except that a clump of 10-15 ES cells was placed in a well with a single CD-1 8 cell morula. Phenotype analysis of G55 1 D mice was carried out on animals maintained in specific pathogen-free conditions on wood shaving bedding and standard rodent food (Norco Cooperative Ltd).
Allele-specific PCR Amplification of DNA prepared from ES colonies or tail-tips for genotyping was carried out using the primers (5'-GACAT CACCA AGTTT GCAGA ACAAG-3') and (5'-GTATA AAGCT TACCG GGTGT GGTG-3') and a thermal profile of 95°C 30 s, 67°C 45 s, 72°C I min for 35 cycles. This primer pair produces a fragment of -640 bp extending from the first nucleotide of exon 11 to 13 bp downstream of exon llb and, in wild-type DNA, has a single BsaI site 83 bp from the 3' end. The mutagenesis of codon 551 results in the introduction of an additional BsaI site such that PCR products from wild-type and cftrG51D alleles differ in length following digestion with BsaI. Semi-quantitative RT-PCR of G551D transcripts was performed essentially as previously described (Delaney et al., 1993) . Products were quantitated by the inclusion of 1 tCi of [32P]ATP in the PCR reaction. The primers used extend from exon 7 to exon 13 and were X7F2 (5'-GCCGT ACAGA TATGG TATGA TTC-3') and SDCF 4 (5'-AAACT GGTCA AAAGT ATCAT ACC-3'). Reactions were terminated in the logarithmic phase of amplification. RT-PCR products corresponding to G551D transcripts can be distinguished from wild-type transcripts by the presence of a single BsaI site.
Relative survival of the CFTR mutant mice For the comparison of survival rates, animals were housed under conventional animal house conditions on Corn cob bedding (R.S.Biotech) and fed standard rodent food CRMX (Special Diet Services). CftrmlUNC mutant mice (Snouwaert et al., 1992) were obtained from the Jackson Laboratories, Bar Harbor.
Histology
Dissected tissues were fixed in ice-cold 4% phosphate-buffered formaldehyde, embedded in paraffin wax and 6 gtm sections were cut and stained with haematoxylin and eosin and periodic acid Schiffs (PAS) reagent. Liver and lung sections were examined with the genotype of the animal coded.
Electrophysiological methodology
Mice (weight 15-53 g) were anaesthetized (tribromoethanol 0.2 ml/10 g intraperitoneally) and a subcutaneous electrode inserted into a hind limb.
Both this and the exploring electrode were connected by Krebs-HEPES of composition (mM): Na+ 140, Cl-152, K+ 6, Ca2+ 2, Mg2+ 1, glucose 10, HEPES 10 to a calomel electrode and, in turn, to a handheld computer connected to a pre-amplifier containing a low-pass signal averaging filter with a time constant of 0.5 s. The offset of the electrodes was recorded prior to measurements, and appropriate corrections made.
Buccal PD was used to validate the integrity of the circuit, acceptable values ranging from -10 to -17 mV. Rectal PD was measured using a double-lumen tube of outer diameter I mm, inserted to a distance of -15 mm. Following the recording of stable values (+ 0.2 mV over 15 s), drugs were perfused at a rate of 40 jl/min through the second lumen. Amiloride (100 ,uM) followed by forskolin (10 gM), each dissolved in Krebs-HEPES, were administered. Following these measurements, an opening was fashioned in the laryngeal cartilage and a tissue plug inserted. A tracheotomy was then made at the junction of the larynx and trachea. For nasal measurements, the exploring electrode consisted of a fine double-lumen plastic tube (outer diameter 0.5 mm) advanced into the left nasal cavity and the stable PD (+ 0.5 mV over 15 s) recorded at -1 mm intervals up to 10 mm. For drug perfusion, the exploring electrode was positioned 5 mm from the external nares. Drugs were perfused through the second lumen in the sequence: amiloride (100 tM in Krebs-HEPES), forskolin (10 ,uM) and ATP [100 ,uM, both in low chloride (6 mM) HEPES-Krebs with gluconate substitution]. The junctional potential between the normal bathing solution and the lowchloride solution was ignored because of paired comparisons. It is unlikely that the paracellular shunt is affected in CF airway epithelium (Widdicombe et al., 1985) .
Following in viva measurements, animals were sacrificed, the trachea, and caecum dissected and placed in Krebs Henseleit solution of composition (mM): Na+ 145.0, Cl-126.0, K+ 5.9, Ca2+ 2.5, Mg2+ 1.2, HCO3-26.0, P042-1.2, So42-1.2, glucose 5.6. The small intestine was placed in an equivalent solution, with the glucose replaced by equimolar mannitol. All tissues were transported to the laboratory on ice and mounted in Ussing chambers of aperture diameter 0.28 cm2 (jejunum and caecum) or 0.03 cm2 (trachea) . Two chambers were obtained from each jejunum and caecum and one from the trachea. Values were subsequently meaned to provide a single measurement for each animal. Both mucosal and serosal surfaces of the tissues were bathed in Krebs Henseleit solution at 37°C, pH 7.4, circulated by 95% 02/5% CO2, with the exception of the jejunum, where glucose was replaced with equimolar mannitol on the mucosal surface. Studies were performed under shortcircuit conditions. Prior to and at the peak/trough of each drug intervention, a 2 IA pulse was passed to allow measurement of tissue conductance.
In the trachea, once stable values were attained, tissues were treated sequentially with amiloride (100 gM), forskolin (10 ,uM) and ATP (100 gM). All drugs were added mucosally. In the jejunum, the sequence of additions was forskolin (10 ,uM, serosally), ionomycin (5 gM, bilaterally), bumetanide (100 gM, serosally), glucose (5.5 mM, mucosally) and phloridzin (200 ,uM, mucosally) . In the caecum, the sequence of additions was forskolin (10 ,uM, serosally), ionomycin (5 ,uM, bilaterally) and bumetanide (100 ,uM, serosally) . Recordings from all animals studied are included in the analyses, with the exception of one animal (cftrl, IUNC/cftrI11IUNC) in which no measurements could be obtained because of technical difficulties. All statistical comparisons were made using the Mann-Whitney U test; the null hypothesis was rejected at P<0.05.
